Benefit of using renal sodium-glucose cotransporter inhibitors 2 (iSGLT-2) in patients with type 2 Diabetes Mellitus and Heart Failure. Electronic Journal Collection Health, v. 12, n. 9, p. e4349, 25 Sep.2020.